Seoung Hoon Lee

Dr. Seoung Hoon Lee


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

8 September 2015 in Journal of Dental Research
Verified
Journal Article
Closed access
KPK.H. Park
K.H. Park
DGD.R. Gu
D.R. Gu
HSH.S. So
H.S. So
KKK.J. Kim
K.J. Kim
SLSeoung Hoon Lee
Seoung Hoon Lee
Cyanidin-3-glucoside (C3G) is one of the major components of anthocyanin, a water-soluble phytochemical. Recent studies demonstrated the chemopreventive and chemotherapeutic activities of C3G in various conditions, including cancer, although the precise effects of C3G on osteoclast and osteoblast differentiation remain unclear. Here, we investigated the role of C3G in the differentiation of bone-associated cells and its underlying mechanism. C3G inhibited receptor activator of nuclear factor kappa-B ligand (RANKL)–mediated osteoclast differentiation and formation in a dose-dependent manner and downregulated the expression of osteoclast differentiation marker genes. Pretreatment with C3G considerably reduced the induction of extracellular signal–regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated kinases activation by RANKL in osteoclast precursor cells. Furthermore, C3G dramatically inhibited the expression of c-Fos and nuclear factor of activated T-cells, cytoplasmic 1, which are important transcription factors for osteoclast differentiation and activation. The formation of osteoclasts in coculture of bone marrow cells and calvaria-derived osteoblasts was also inhibited by C3G treatment, although the expression of macrophage colony-stimulating factor and RANKL (master factors for osteoclast differentiation and formation) and osteoprotegerin (a decoy receptor for RANKL) on osteoblasts was unaffected. The inhibitory effect of C3G on osteoclastogenesis is therefore targeted specifically to osteoclasts but not osteoblasts. Moreover, analysis of the expression levels of osteoblast differentiation marker genes and alizarin red staining showed that osteoblast differentiation and matrix formation increased after C3G treatment. Taken together, these results strongly suggest that C3G has a dual role in bone metabolism, as an effective inhibitor of osteoclast differentiation but also as an activator of osteoblast differentiation. Therefore, C3G may be used as a potent preventive or therapeutic agent for bone-related diseases, such as osteoporosis, rheumatoid arthritis, and periodontitis.

1 June 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SOSe Jeong Oh
Se Jeong Oh
DGDong Ryun Gu
Dong Ryun Gu
SJSu Hyun Jin
Su Hyun Jin
KPKeun Ha Park
Keun Ha Park
SLSeoung Hoon Lee
Seoung Hoon Lee

1 June 2020 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
DPDanbi Park
Danbi Park
MKMin Kim
Min Kim
JCJin Woo Choi
Jin Woo Choi
JBJEONG-HWA BAEK
JEONG-HWA BAEK
SLSeoung Hoon Lee
Seoung Hoon Lee
KBKyunghwa Baek
Kyunghwa Baek

1 January 2013 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
Seunghan OhSeunghan Oh
Seunghan Oh
KMKyung Suk Moon
Kyung Suk Moon
SLSeoung Hoon Lee
Seoung Hoon Lee
The purpose of this research was to characterize an Arg‐Gly‐Asp (RGD) peptide immobilized on TiO2 nanotubes. In addition, we investigated the effects of the RGD peptide‐coated TiO2 nanotubes on the cellular response, proliferation, and functionality of osteogenic‐induced human mesenchymal stem cells (hMSCs), which are osteoclasts that have been induced by bone marrow macrophages. The RGD peptide was grafted covalently onto the surface of TiO2 nanotubes based on the results of SEM, FT‐IR, and XPS. Furthermore, the RGD peptide promoted the initial attachment and proliferation of the hMSCs, regardless of the size of the TiO2 nanotubes. However, the RGD peptide did not prominently affect the osteogenic functionality of the hMSCs because the peptide suppressed hMSC motility associated with osteogenic differentiation. The result of an in vitro osteoclast test showed that the RGD peptide accelerated the initial attachment of preosteoclasts and the formation of mature osteoclasts, which could resorb the bone matrix. Therefore, we believe that an RGD coating on TiO2 nanotubes synthesized on Ti implants might not offer significant acceleration of bone formation in vivo because osteoblasts and osteoclasts reside in the same compartment.

31 July 2018 in BMB Reports
Verified
Journal Article
Open access
PDF file
SJSu Hyun Jin
Su Hyun Jin
HKHyunsoo Kim
Hyunsoo Kim
DGDong Ryun Gu
Dong Ryun Gu
KPKeun Ha Park
Keun Ha Park
YLYoung Rae Lee
Young Rae Lee
SLSeoung Hoon Lee
Seoung Hoon Lee
Su Hyun Jin, Hyunsoo Kim, Dong Ryun Gu, Keun Ha Park, Young Rae Lee, Yongwon Choi, and Seoung Hoon Lee. BMB Reports 2018;51:356-61. https://doi.org/10.5483/BMBRep.2018.51.7.106